跳至主要内容
临床试验/CTRI/2025/09/095002
CTRI/2025/09/095002尚未招募2 期

Clinical evaluation of kshara basti and alambushadi churna on amavata

PATANJALI BHARTIYA AYURVIGYAN EVAM ANUSANDHAN SANSTHAN HARIDWAR1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年9月29日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
RA factor, ESR, CRP

研究概览

简要总结

This open-label, single arm clinical trial will evaluate the efficacy and safety of Kshara Basti followed by Alambushadi Churna in patients of Amavata (Rheumatoid Arthritis). 40 patients fulfilling ACR/EULAR 2010 criteria will be enrolled from OPD/IPD of Kayachikitsa/ Panchkarma, Patanjali Ayurvigyan Evam Anusandhan Sansthan, Haridwar. The intervention aims to provide safe and effective Ayurvedic management of Amavata.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Patients of Amavata with features of Rheumatoid Arthritis as specified in 2010 ACR- EULAR classification Age- 18- 65 years, irrespective of gender, caste, religion, etc Patients who are fit for BASTI KARMA as described in Charak Siddhi sthana.

排除标准

  • Patient with history of Impaired cardiac, renal, hepatic disorders Known inherited genetic syndrome Patients with known history of any direct or indirect trauma on joints Pregnancy and / or lactating mother.

结局指标

主要结局

RA factor, ESR, CRP

时间窗: 0 day, 30 day, 60 day

次要结局

  • joint pain(tenderness around the joints)

研究者

发起方
PATANJALI BHARTIYA AYURVIGYAN EVAM ANUSANDHAN SANSTHAN HARIDWAR
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

PRIYANKA SARKAR

PATANJALI BHARTIYA AYURVIGYAN EVAM ANUSANDHAN SANSTHAN HARIDWAR

研究点 (1)

Loading locations...

相似试验